Confideo, LLC

What Confideo, LLC does

Confideo, LLC is a founder-owned digital healthcare media firm founded in 2013, headquartered in New York City with a second office in Philadelphia. The company operates through three coordinated divisions: Confideo Labs produces immersive multimedia content (virtual reality, augmented reality, mixed reality, and proprietary volumetric video using 100+ camera arrays) for pharmaceutical and life sciences clients; Confideo Media provides digital marketing services including media planning, buying, hyper-targeting, progressive analytics, and omnichannel campaign optimization; and Confideo Ventures delivers management consulting plus strategic equity investments in early-stage healthtech, biotech, and media companies. Its core production differentiator is a proprietary volumetric video capture process that creates 3D holographic AR deployments — for example, a GPP campaign for Boehringer Ingelheim featuring patient holograms Robert and Emma, which won the MM&M Gold for Best Use of Immersive Technology in 2022.

The company serves enterprise pharmaceutical and biotech clients including Boehringer Ingelheim, Moderna, Dynavax, Coherus Oncology, Coherus Biosciences, Puma Biotech, and Sound Healthcare, with use cases spanning HCP education, branded immersive sales aids, disease state campaigns, oncology marketing, and AI-enabled real-time social engagement analytics. Business model is professional services on a quote-based, project-specific pricing structure tailored to campaign scope. Distribution is direct enterprise field sales with consultative senior-level engagement; no resellers or channel partners. Confideo has earned 11 consecutive years of industry recognition across PM360 Trailblazer Awards, MM&M Awards, ELITE Awards, Telly, Communicator, Davey, Vega, DotComm, Hermes, W3, APEX, and MedAdNews.

Operating scale is intentionally compact at 1-10 employees, reflecting a senior-only service model rather than a scaling agency. The firm has no institutional funding, no parent company, and no disclosed M&A activity; it is privately held under founder Mike Marett, who has been recognized among LifeSciVoice Top Industry Leaders. Geographic footprint is United States-only with no global expansion claims. The strategic posture is that of a specialized boutique: deep domain expertise in healthcare immersive media, sustained award authority, and an integrated three-division model that captures value across production, media services, and equity participation in the healthtech ecosystem.

Name

Confideo, LLC

Legal name

Confideo, LLC

Website

https://confideolabs.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

1–10 employees

Short description

Confideo, LLC is a founder-owned healthcare media firm operating Confideo Labs (immersive VR/AR/volumetric video production), Confideo Media (digital marketing and analytics), and Confideo Ventures (consulting and healthtech investments), serving enterprise pharmaceutical and biotech clients with specialized immersive campaigns and HCP education programs.

Ownership category

akta.pro rank

Product category

Immersive Healthcare Media Services

NAICS

Advertising, Public Relations, and Related Services (5418), Media Buying Agencies (541830)

SIC

Services-Advertising Agencies (7311)

akta.pro primary industry

Healthcare/Pharma Creative Agencies (MPAAAAAJ)

akta.pro secondary industry

Mobile/Digital Experiential (AR/VR, Interactive Installations) (MPAAAGAI)

Keywords

• Immersive healthcare media
• Pharmaceutical marketing services
• Volumetric video production
• Augmented reality experiences
• Digital healthcare advertising

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Professional Services - Immersive Media Design and Development: Confideo designs, develops, and deploys immersive multimedia tactics and strategies for healthcare clients, including VR, AR, and volumetric video productions. Revenue is generated through project-based professional services engagements with pharmaceutical and life sciences companies.
2. Management Consulting Services: Confideo Ventures provides strategy, marketing, media, corporate development, and business development consulting services to emerging health-tech organizations to accelerate their commercial businesses.
3. Digital Marketing and Media Services: Confideo Media provides digital marketing and media services including intelligent digital media planning, media buying, strategic campaign optimization, and analytics and measurement. Services include data segmentation, hyper-targeting, and media optimization across omnichannel opportunities.
4. Strategic Investments: Confideo Ventures comprises a consortium that makes strategic investments in early-stage technology, health-tech, biotech, and media companies, generating returns through portfolio company exits and equity appreciation.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

Confideo, LLC is a healthcare-focused digital media firm that designs, develops, and deploys immersive multimedia tactics and strategies for pharmaceutical and life sciences clients. Through its three divisions it delivers VR, AR, mixed reality, and proprietary volumetric video productions; digital media planning, buying, and analytics; and management consulting and strategic investments to health-tech and biotech companies.

Product overview

Confideo, LLC operates as a healthcare media company with three interconnected divisions. Confideo Labs serves as the core immersive media production unit, creating VR, AR, mixed reality, and volumetric video content for pharmaceutical and healthcare clients. Confideo Media extends the offering with digital marketing services, analytics, and media strategy capabilities. Confideo Ventures provides management consulting and strategic investments to early-stage health-tech companies, creating an ecosystem that supports the full lifecycle from emerging technology to commercial deployment.

Differentiator

Problem solved

Functional benefit

Products and services

• Confideo Labs Award-winning digital media division that designs, develops, and deploys immersive multimedia (VR, AR, mixed reality, and proprietary volumetric video) tactics and strategies for pharmaceutical and life sciences clients to support HCP education, brand marketing, and stakeholder engagement.
• Confideo Media Digital marketing and media services division providing data segmentation, hyper-targeting, progressive analytics, omnichannel media planning, media buying, and real-time campaign optimization for healthcare brands.
• Confideo Ventures Management consulting and strategic investment arm providing strategy, marketing, media, corporate development, and business development services to early-stage health-tech, biotech, and media companies, and making strategic investments in those companies.

Quantifiable outcome

• Virtual reality content retention rates as high as 90%
• +2 more outcomes

Named customers7 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Six partnerships are on record, tiered major and minor.

• Cohero HealthmajorStrategic or Co-development PartnerConfideo Ventures engaged early with Cohero Health to bolster its commercial evolution, guiding the company from a young concept to a well-established and award-winning business that gained exponential traction. Mike and his team led corporate strategy, brand development, market positioning, and advancement of Cohero's product mix. Cohero Health was later acquired by Aptar Pharma.
• Avalyn PharmaminorStrategic or Co-development PartnerConfideo Ventures has worked with Avalyn Pharma, which raised significant funding ($175M Series C, $100M Series D) for its inhaled pulmonary fibrosis therapy programs.
• Eirion TherapeuticsminorStrategic or Co-development PartnerConfideo Ventures has worked with Eirion Therapeutics, a company developing next-generation neuromodulators. Eirion announced a $40M Series A investment and licensing deal and initiated first-in-human clinical trials.
• Mint HouseminorStrategic or Co-development PartnerConfideo Ventures has worked with Mint House, a hotel startup that raised $35M to target business travelers.
• CentivominorStrategic or Co-development PartnerConfideo Ventures has worked with Centivo, a company that acquired virtual-first medical provider Eden Health and secured $34M Series B funding to scale self-funded employer health plans.
• Area 23 (IPG Health Company)majorStrategic or Co-development PartnerConfideo Labs collaborated with Area 23 (an IPG Health company) and Boehringer Ingelheim to win the PM360 Trailblazer Award for Best Interactive/Immersive Marketing Program in 2022. Area 23 served as the creative agency partner in this multi-company collaboration.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Market position

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/ConfideoLabs
• LinkedInlinkedin.com/company/confideo-llc

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Confideo, LLC